TenSixteen Bio is a biotechnology company focused on developing novel therapeutics for a variety of diseases.
TenSixteen Bio has raised $40.0M in total funding. The most recent round was Series A. The last funding was announced in January 2022.
TenSixteen Bio's investors include Foresite Capital, Google Ventures.
TenSixteen Bio is headquartered in San Francisco, United States.
TenSixteen Bio is a biotechnology company focused on developing novel therapeutics for a variety of diseases.
TenSixteen Bio is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"TenSixteen Bio — Funding & Investors." VCBacked, January 27, 2022, https://www.vcbacked.co/company/tensixteen-bio. Accessed August 15, 2026.
VCBacked. (2022). TenSixteen Bio — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/tensixteen-bio
{{cite web |title=TenSixteen Bio — Funding & Investors |url=https://www.vcbacked.co/company/tensixteen-bio |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated